Universite d'Evry Val d'Essonne
Records under this name other than the patents Universite d'Evry Val d'Essonne holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 21 patents it holds.
Back to Universite d'Evry Val d'Essonne
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,012,425 | Methods for the Treatment of Leber Congenital Amaurosis now held by Université Paris Cité In force · High confidence | In force | High confidence | |
| US 9,487,782 | Methods for the Treatment of Leber Congenital Amaurosis now held by Université Paris Cité In force · Medium confidence | In force | Medium confidence | |
| US 9,777,272 | Methods for the Treatment of Leber Congenital Amaurosis now held by Université Paris Cité In force · Medium confidence | In force | Medium confidence | |
| US 12,037,362 | Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism In force · High confidence | In force | High confidence | |
| US 11,384,351 | Methods and Tools for Purifying Nucleic Acids and Using Polymerized Tubulin now held by Inserm (Institut National de la Sante et de la Recherche Medicale) and Universite d'Evry - Val d'Essone Lapsed on the fee record Ended Jul 12, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 12, 2026 | Medium confidence |
| US 11,371,061 | Compositions and Methods for Improving Viral Vector Efficiency held by Genethon, Inserm (Institut National de la Sante et de la Recherche Medicale) and Universite d'Evry Val d'Essonne Lapsed on the fee record Ended Jun 28, 2026 · High confidence | Lapsed on the fee record | Ended Jun 28, 2026 | High confidence |
| US 11,298,348 | Combination Treatment of Sarcoglycanopathies held by Inserm (Institut National de la Sante et de la Recherche Medicale), Universite d'Evry-Val-D'Essonne, Genethon and Universita' Degli Studi Di Padova Lapsed on the fee record Ended Apr 12, 2026 · High confidence | Lapsed on the fee record | Ended Apr 12, 2026 | High confidence |
| US 11,104,897 | Compositions and Methods for the Treatment of Nucleotide Repeat Expansion Disorders held by Genethon, Inserm (Institut National de la Sante et de la Recherche Medicale) and Universite d'Evry Val d'Essonne Lapsed on the fee record Ended Aug 31, 2025 · High confidence | Lapsed on the fee record | Ended Aug 31, 2025 | High confidence |
| 12/734,854 | Functionalized Biochips for Spr-Ms Coupling Abandoned Abandoned Jun 1, 2016 | Abandoned | Abandoned Jun 1, 2016 | |
| 13/807,089 | CALPAIN-3 Inhibitors for Treating Muscular Dystrophies and Cardiomyopathies held by Genethon and Universite d'Evry Val d'Essonne Abandoned Abandoned Jun 9, 2014 | Abandoned | Abandoned Jun 9, 2014 |